Rapport Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Rapport Therapeutics Inc
TickerRAPP
CIK #0002012593
CUSIP75383L102
SectorLife Sciences - Pharmaceutical Preparations
Address1325 Boylston Street Suite 401, Boston, MA 02215
Source [EDGAR]
CIK Filing 2011 - 2025
[0002012593] 10-K
[0002012593] 10-Q
[0002012593] 3
[0002012593] 4
[0002012593] 8-K
[0002012593] SC 13D
[0002012593] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Third Rock Ventures V LP Rapport Therapeutics Inc [2025-02-13] 0.0
Arch Venture Fund XII LP Rapport Therapeutics Inc [2024-11-14] 10.2
Capital International Investors Rapport Therapeutics Inc [2024-11-13] 7.1
Johnson & Johnson Rapport Therapeutics Inc [2024-10-18] 6.8
FMR LLC Rapport Therapeutics Inc [2024-07-10] 0.0
Goldman Sachs Group Inc Rapport Therapeutics Inc [2024-06-21] 7.5
Cormorant Asset Management LP Rapport Therapeutics Inc [2024-06-20] 3.51
Sofinnova Venture Partners Xi LP Rapport Therapeutics Inc [2024-06-14] 11.0
Form 3/4/5 Filer 2011 - 2025
Bredt David
Rapport Therapeutics, Inc.
Young Wendy B.
Maraganore John
Healy James
Perez Robert J
Huber Reid M
Paul Steven M
Silva Paul M
Sanchez Ramiro
Sevigny Jeffrey
Ignelzi Troy A.
Gault Cheryl
Yeleswaram Krishnaswamy
Ceesay Abraham
TRV GP VI LLC
Third Rock Ventures GP VI, L.P.
Third Rock Ventures V, L.P.
TRV GP V LLC
Third Rock Ventures VI, L.P.
Third Rock Ventures GP V, LP
Galer Bradley S.
ARCH Venture Partners XII, LLC
Crandell Keith
Gillis Steven
ARCH Venture Fund XII, L.P.
Nelsen Robert
ARCH Venture Partners XII, L.P.
Burow Kristina
Burrell Terry-Ann
Tong Jeffrey K
Form 13F Holdings
Firm Period DFND Voting Shares
TRV GP V LLC [2025-06-30] SOLE 7,135,233 7,135,233
FMR LLC [2025-06-30] DFND 5,474,633 5,474,633
Arch Venture Management LLC [2025-06-30] SOLE 0 3,728,738
Cormorant Asset Management LP [2025-06-30] DFND 2,940,921 2,940,921
Capital International Investors [2025-06-30] DFND 2,602,529 2,602,529
Johnson & Johnson [2025-06-30] DFND 0 2,498,051
Sofinnova Investments Inc [2025-06-30] SOLE 1,995,594 1,995,594
Goldman Sachs Group Inc [2025-06-30] DFND 1,235,035 1,235,035
BlackRock, Inc. [2025-06-30] SOLE 1,189,642 1,219,201
AllianceBernstein LP [2025-06-30] DFND 1,122,124 1,154,688
Vanguard Group Inc [2025-06-30] SOLE 0 1,096,839
TRV GP VI LLC [2025-06-30] SOLE 969,218 969,218
Baker Bros Advisors LP [2025-06-30] SOLE 550,090 550,090
Siren, L.L.C. [2025-06-30] DFND 378,469 378,469
Geode Capital Management LLC [2025-06-30] DFND 333,159 333,159
State Street Corp [2025-06-30] DFND 279,608 298,708
UBS Group AG [2025-06-30] DFND 273,507 273,507
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 243,880 243,880
Logos Global Management LP [2025-06-30] SOLE 208,910 208,910
Affinity Asset Advisors LLC [2025-06-30] SOLE 199,643 199,643
TD Asset Management Inc [2025-06-30] SOLE 196,870 196,870
Ensign Peak Advisors, Inc [2025-06-30] SOLE 194,200 194,200
Woodline Partners LP [2025-06-30] SOLE 185,028 185,028
Sectoral Asset Management Inc [2025-06-30] SOLE 0 179,860
Driehaus Capital Management LLC [2025-06-30] SOLE 131,340 131,340
Northern Trust Corp [2025-06-30] DFND 113,528 113,784
Manufacturers Life Insurance Company the [2025-06-30] DFND 100,424 100,424
Deep Track Capital LP [2025-06-30] SOLE 98,237 98,237
Charles Schwab Investment Management Inc [2025-06-30] SOLE 93,497 93,497
Barclays PLC [2025-06-30] SOLE 71,108 71,108
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com